NCT03188900已完成不适用
New Therapeutic Strategy Against Preeclampsia: Angiogenic Switch to Physiological State by Extracorporeal Removal of sFlt-1
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 236
- 试验地点
- 1
- 主要终点
- ratio sFlt-1/PlGF
研究概览
简要总结
The aim of the study is to setup a collection of maternal plasma and serum from patients with preeclampsia and normal pregnancy for in vitro validation of new therapeutics based on extra-corporal removal of sFlt-1
详细描述
A collection of maternal plasma and serum from patients with preeclampsia (PE) and normal pregnancy (NP) :
- Between 20WG and 23WG+6D : 20 patients with PE and 30 patients with NP
- Between 24WG and 27WG+6D : 20 patients with PE and 30 patients with NP
- Between 28WG and 31WG+6D : 20 patients with PE and 30 patients with NP
- Between 32WG and 35WG+6D : 20 patients with PE and 30 patients with NP
- Between 36WG and 40WG+6D : 20 patients with PE and 30 patients with NP
研究设计
- 研究类型
- Observational
- 观察模型
- Case Control
- 时间视角
- Prospective
入排标准
- 年龄范围
- 18 Years 至 50 Years(Adult)
- 性别
- Female
- 接受健康志愿者
- 否
入选标准
- •Age from 18 to 50 years old
- •Singleton pregnancies between 20 and 41 weeks of gestation
- •Preeclampsia
- •Normal pregnancy
排除标准
- •Infectious disease: HIV, HBV or HCV
- •Multiple pregnancies
- •Opposition of the patient
结局指标
主要结局
ratio sFlt-1/PlGF
时间窗: Day 0
measurement of of sFlT-1 and PlGF
次要结局
- Kinetics of these ratios sFlt-1/PlGF during pregnancy(until 5 month)
研究者
研究点 (1)
Loading locations...
相似试验
招募中
不适用
New Therapeutic Strategy Against PreeclampsiaPreeclampsiaNCT06464159Assistance Publique - Hôpitaux de Paris100
终止
3 期
Prevention of Preeclampsia With Aspirin in Recipients of Donated Oocytes.Pre-EclampsiaNCT02174328Instituto de Investigacion Sanitaria La Fe81
已完成
不适用
PREPARE, Prematurity Reduction by Pre-eclampsia CarePre-EclampsiaPremature BirthNCT03073317Instituto Fernandes Figueira1,250
招募中
不适用
EV Based Platform for Monitoring Therapeutics Response During Pregnancy (ARISE)PreeclampsiaNCT06249178Ohio State University1,000
已完成
不适用
Novel Biomarkers of Preeclampsia, Aquaporin, Fatty Acid, and S110BPreeclampsiaNCT03567551University of Alabama at Birmingham126
